Plain-English translation of NCT06576466 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether creatine monohydrate, a nutritional supplement, can help people recover better after an ischemic stroke. The study will compare people who receive the supplement alongside standard stroke care to those who receive a placebo (an inactive powder that looks the same). Researchers believe this medication may help rebuild muscle strength and improve physical recovery during the crucial weeks after a stroke.
After a stroke, patients often lose muscle mass, strength, and physical function, and there are few treatments available to help with recovery once the stroke has happened. This medication has shown promise in improving muscle strength and reducing inflammation in other populations, so researchers want to see if it could help stroke patients regain their independence and quality of life more quickly.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive either the supplement or a placebo powder to take by mouth for 12 weeks. The first week involves a higher dose, then a lower dose for the remaining 11 weeks. You'll continue your regular stroke rehabilitation and medical care. The study team will measure your strength, physical function, and recovery at various points to see if the supplement helps you regain ability to move and perform daily activities.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Spain